Insights From Technical Analysis
Is Alterity Therapeutics (ASX: ATH) Stabilising After Volatility at a Key Technical Level?
Alterity Therapeutics (ASX: ATH) is advancing its lead neurodegeneration drug, ATH434, toward Phase 3 trials. Following positive clinical data and a 1-for-50 share consolidation, the stock is holding key technical support around 0.450, awaiting a potential upside breakout.
Can Hammer Metals (ASX: HMX) Sustain Its Breakout Above Long-Term Resistance?
Hammer Metals, a junior explorer focused on copper, gold and lithium in Queensland and WA, broke above resistance on strong Kalman drilling and a trading halt tied to a potential control deal, though overbought technicals and exploration risk remain.
Has Ardea Resources (ASX: ARL) Identified a Major Support Floor After Its Steep Pullback from Its Highs?
Ardea Resources (ASX: ARL) is an Australian critical minerals developer whose stock has pulled back sharply from 2026 highs, pressured by a DFS delay at its world-class Kalgoorlie Nickel Project, weak nickel prices, and thin institutional support, while technical indicators suggest the $0.50 level may act as a key support floor.
SRJ Technologies (ASX: SRJ) Explodes Higher as Contract Wins Ignite Buying Frenzy
SRJ Technologies has attracted strong investor interest following the securing of multiple energy-sector contracts, including major UAE robotic inspection projects. Growing adoption of BoltEx® technology, expanding Middle East operations, and a strengthening recurring revenue pipeline have boosted confidence in the company's growth outlook.
EBR Systems (ASX: EBR) Slumps to New Lows as Capital Raise Sparks Investor Exit
EBR Systems has fallen sharply after a major capital raise sparked dilution concerns. Despite the sell-off, the company continues to expand the commercialisation of its FDA-approved WiSE CRT heart-failure technology, supported by growing implant volumes, clinical studies, and international regulatory progress.
Cygnus (ASX: CY5) Shares Soar on A$232M Takeover Bid; 60% Premium Sends CY5 Rallying
Cygnus Metals (ASX: CY5) has surged after a A$232 million takeover offer from Central Asia Metals, offering a 60% premium. The company focuses on developing its high-grade Chibougamau Copper-Gold Project in Québec, alongside lithium and base-metal exploration, while expanding resources through drilling and capital raising.